PHARMA TECHNOLOGY A/S: Financial statements 2013
CVR: 20826746
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 12,826,166 and a net result of DKK 3,566,626 compared with DKK 1,428,526 the year before. That is an increase of 114.2% compared with the year before. Equity in the 2013 report amounted to DKK 4,066,626. The solvency ratio was 38.4%.
- Gross Profit
- DKK 12,826,166
- Profit/Loss
- DKK 3,566,626
- Equity
- DKK 4,066,626
- Total Assets
- DKK 10,593,349
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 12.8 mio. | 3.6 mio. | 4.1 mio. | - |
| 2012 | - | 6 mio. | 1.4 mio. | 1.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMA TECHNOLOGY A/S has published its annual report for 2012. Gross profit came to DKK 5,987,257, and the net result was DKK 1,428,526.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.